Intention-To-Treat (ITT) Analysis

From GM-RKB
Jump to navigation Jump to search

An Intention-To-Treat (ITT) Analysis is a Clinical Analysis Method that evaluates clinical trial results based on initial pre-assigned medical treatment and not on the one actually received.



References

2022a

  • (Wikipedia, 2022a) ⇒ https://en.wikipedia.org/wiki/Intention-to-treat_analysis Retrieved:2022-3-19.
    • In medicine an intention-to-treat (ITT) analysis of the results of an experiment is based on the initial treatment assignment and not on the treatment eventually received. ITT analysis is intended to avoid various misleading artifacts that can arise in intervention research such as non-random attrition of participants from the study or crossover. ITT is also simpler than other forms of study design and analysis, because it does not require observation of compliance status for units assigned to different treatments or incorporation of compliance into the analysis. Although ITT analysis is widely employed in published clinical trials, it can be incorrectly described and there are some issues with its application.[1] Furthermore, there is no consensus on how to carry out an ITT analysis in the presence of missing outcome data.
  1. Hollis, Sally; Campbell, Fiona (September 1999). "What is meant by intention to treat analysis? Survey of published randomised controlled trials". BMJ. 319 (7211): 670–674. doi:10.1136/bmj.319.7211.670. PMC 28218. PMID 10480822

2022b

  • (Wikipedia, 2022b) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research#I Retrieved:2022-3-19.
    • QUOTE: Intent to treat
      • Analysis of clinical trial results that includes all data from participants in the groups to which they were randomized even if they never received the treatment. (NLM)
      • The principle that asserts that the effect of a treatment policy can be best assessed by evaluating on the basis of the intention to treat a subject (i.e. the planned treatment regimen) rather than the actual treatment given. It has the consequence that subjects allocated to a treatment group should be followed up, assessed and analysed as members of that group irrespective of their compliance to the planned course of treatment. (ICH E9)

2017

2011

  1. Fisher LD, Dixon DO, Herson J, Frankowski RK, Hearron MS, Peace KE. Intention to treat in clinical trials. In: Peace KE, editor. Statistical issues in drug research and development. New York: Marcel Dekker; 1990. pp. 331–50.
  2. Newel DJ. Intention-to-treat analysis: Implications for quantitative and qualitative research. In: Int J Epidemiol. 1992;21:837–41.
  3. Wertz RT. Intention to treat: Once randomized, always analyzed. Clin Aphasiol. 1995;23:57–64.
  4. 4.0 4.1 Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: The intention-to-treat principle. Med J Aust. 2003;179:438–40.
  5. LaValley MP. Intent-to-treat analysis of randomized clinical trials. 2003. [Last accessed on 2011 Jan 12]. Available from: http://people.bu.edu/mlava/ITT%20Workshop.pdf
  6. Hennekens CH, Buring JE, Mayrent SL. Boston: Little, Brown; 1987. Epidemiology in Medicine; p. 207.
  7. Hennekens CH, Buring JE, Mayrent SL. Boston: Little, Brown; 1987. Epidemiology in Medicine; p. 207.

2002